299. 嚢胞性線維症 Cystic fibrosis Clinical trials / Disease details


臨床試験数 : 1,695 薬物数 : 1,527 - (DrugBank : 268) / 標的遺伝子数 : 111 - 標的パスウェイ数 : 174

  
2 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04496921
(ClinicalTrials.gov)
August 10, 202021/7/2020Vitamin K Supplementation to Reduce Deficiencies in Adults With Cystic FibrosisVitamin K Supplementation to Reduce Deficiencies in Adults With Cystic Fibrosis : A Pilot StudyCystic FibrosisDietary Supplement: Vitamin K supplementation, dose #1;Dietary Supplement: Vitamin K supplementation, dose #2Institut de Recherches Cliniques de MontrealUniversité de MontréalWithdrawn18 YearsN/AAll0N/ACanada
2EUCTR2006-000945-20-GB
(EUCTR)
22/08/200618/09/2006To investigate the effect of vitamin K supplementation on markers of bone turnover and bone density in adolescents and adults with cystic fibrosis - Vitamin K supplementation in Cystic FibrosisTo investigate the effect of vitamin K supplementation on markers of bone turnover and bone density in adolescents and adults with cystic fibrosis - Vitamin K supplementation in Cystic Fibrosis Cystic Fibrosis
MedDRA version: 8.1;Level: LLT;Classification code 10011762;Term: Cystic fibrosis
Trade Name: Menadiol Diphosphate
Product Name: Menadiol Diphosphate
Product Code: Menadiol Diphosphate
INN or Proposed INN: Menadiol sodium diphosphate
Barts and the London NHS TrustNULLNot Recruiting Female: yes
Male: yes
40 Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): no Therapeutic confirmatory - (Phase 3): yes Therapeutic use (Phase 4): noUnited Kingdom